Darmkarzinom
Colopredict Register Plus 2.0
Retro- und prospektive Erfassung der Rolle von MSI und KRAS für die Prognose beim Kolonkarzinom im Stadium I + II + III und hochsitzendes Rektumkarzinom Stadium I + II + III (prospektiv)
QUINTIS
A Randomized Phase II Trial Evaluating Fruquintinib in Combination with Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer without Active Liver Metastases
PROTECTOR
Pre-Operative Treatment in rEseCTable cOlon canceR
Prospective, randomized, open, multicenter Phase III trial to investigate the efficacy preoperative systemic therapy in advanced colon cancer
FIRE-9 Port
Post-resection/ablation chemotherapy in patients with metastatic colorectal cancer – Prospective, randomized, open, multicenter Phase III trial to investigate the efficacy of active post-resection/ablation therapy in patients with metastatic colorectal cancer